In addition, the prothrombotic effect of the COX-2 inhibitor through endothelium damage can increase the risk of cerebrovascular disease, which also contributes to cardiovascular risks and gastrointestinal bleeding (Hersh et al. 2007; Lapi et al. 2016; Fanelli et al. 2017). Here, PTGS2 is linked to cerebrovascular disorder.